Metraipolis › archive › dc_11edc4126e79

Novel 1-(2-Aryl-2-adamantyl)piperazine Derivatives Exhibit In Vitro Anticancer Activity Across Various Human Cancer Cell Lines, with Selective Efficacy… — Europe PMC PMID:41155718

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155718
DOI
10.3390/medicina61101731
License (as archived)
solo-consultazione
Archived
2026-11-09T19:05:57.777Z
SHA-256 of the archived text
723113dc7cccc333f6cbe968450d48111fa62de476f75e013fb2e52665b9512f
Stable URL of this page
https://metraipolis.com/documento/dc_11edc4126e79

How to cite

Novel 1-(2-Aryl-2-adamantyl)piperazine Derivatives Exhibit In Vitro Anticancer Activity Across Various Human Cancer Cell Lines, with Selective Efficacy… — Europe PMC PMID:41155718 — Europe PMC (en), https://europepmc.org/article/MED/41155718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11edc4126e79 (Metraipolis archive dc_11edc4126e79, sha256 723113dc7cccc333f6cbe968450d48111fa62de476f75e013fb2e52665b9512f)
BibTeX
@misc{dc11edc4126e79,
  title = {Novel 1-(2-Aryl-2-adamantyl)piperazine Derivatives Exhibit In Vitro Anticancer Activity Across Various Human Cancer Cell Lines, with Selective Efficacy… — Europe PMC PMID:41155718},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155718},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11edc4126e79; sha256 723113dc7cccc333f6cbe968450d48111fa62de476f75e013fb2e52665b9512f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155718. Agents can read the archived copy with the MCP tool read_document.